Company research / NNVC

Nanoviricides, Inc. (NNVC)

SEC name NANOVIRICIDES, INC. · CIK 0001379006 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Jun 30

For the year ended 2026-06-30, Nanoviricides, Inc. reported revenue of $0.

Key ratios (year ended 2026-06-30)

-94.7%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form DEF 14A (proxy statement) · 2026-10-08

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView